Global Non-24-hour Sleep-wake Disorder Treatment Market Growth (Status and Outlook) 2026-2032
The global Non-24-hour Sleep-wake Disorder Treatment market size is predicted to grow from US$ 554 million in 2025 to US$ 845 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual"s biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
United States market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-24-hour Sleep-wake Disorder Treatment players cover Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Non-24-hour Sleep-wake Disorder Treatment Industry Forecast” looks at past sales and reviews total world Non-24-hour Sleep-wake Disorder Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-24-hour Sleep-wake Disorder Treatment sales for 2026 through 2032. With Non-24-hour Sleep-wake Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-24-hour Sleep-wake Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Non-24-hour Sleep-wake Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-24-hour Sleep-wake Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-24-hour Sleep-wake Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-24-hour Sleep-wake Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-24-hour Sleep-wake Disorder Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-24-hour Sleep-wake Disorder Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual"s biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
United States market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-24-hour Sleep-wake Disorder Treatment players cover Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Non-24-hour Sleep-wake Disorder Treatment Industry Forecast” looks at past sales and reviews total world Non-24-hour Sleep-wake Disorder Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-24-hour Sleep-wake Disorder Treatment sales for 2026 through 2032. With Non-24-hour Sleep-wake Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-24-hour Sleep-wake Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Non-24-hour Sleep-wake Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-24-hour Sleep-wake Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-24-hour Sleep-wake Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-24-hour Sleep-wake Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-24-hour Sleep-wake Disorder Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-24-hour Sleep-wake Disorder Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prescription Drugs
- OTC
- Hospital Pharmacies
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Mylan
- Nature’s Bounty
- Otsuka Pharma (Pharmavite)
- Boiron
- Miers Laboratories
- Genexa
- Homeocan
- Clinigen Group
- Vanda Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (2021-2032)
2.1.2 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-24-hour Sleep-wake Disorder Treatment by Country/Region (2021, 2025 & 2032)
2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC
2.2.3 Non-24-hour Sleep-wake Disorder Treatment Market Size by Type
2.2.3.1 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
2.3 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
2.3.4.1 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SIZE BY PLAYER
3.1 Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Player
3.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2021-2026)
3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT BY REGION
4.1 Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.4 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.5 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026)
5.2 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
5.3 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026)
6.2 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
6.3 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment by Region (2021-2026)
8.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST
10.1 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.1.2 Americas Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.3 APAC Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.4 Europe Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.5 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2 Americas Non-24-hour Sleep-wake Disorder Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.2 Canada Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.3 Mexico Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.4 Brazil Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3 APAC Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.3.1 China Non-24-hour Sleep-wake Disorder Treatment Market Forecast
10.3.2 Japan Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.3 Korea Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.4 Southeast Asia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.5 India Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.6 Australia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4 Europe Non-24-hour Sleep-wake Disorder Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.2 France Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.3 UK Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.4 Italy Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.5 Russia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.2 South Africa Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.3 Israel Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.4 Turkey Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.6 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Type (2027-2032)
10.7 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-24-hour Sleep-wake Disorder Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mylan Main Business Overview
11.2.5 Mylan Latest Developments
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Information
11.3.2 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nature’s Bounty Main Business Overview
11.3.5 Nature’s Bounty Latest Developments
11.4 Otsuka Pharma (Pharmavite)
11.4.1 Otsuka Pharma (Pharmavite) Company Information
11.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Otsuka Pharma (Pharmavite) Main Business Overview
11.4.5 Otsuka Pharma (Pharmavite) Latest Developments
11.5 Boiron
11.5.1 Boiron Company Information
11.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boiron Main Business Overview
11.5.5 Boiron Latest Developments
11.6 Miers Laboratories
11.6.1 Miers Laboratories Company Information
11.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Miers Laboratories Main Business Overview
11.6.5 Miers Laboratories Latest Developments
11.7 Genexa
11.7.1 Genexa Company Information
11.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Genexa Main Business Overview
11.7.5 Genexa Latest Developments
11.8 Homeocan
11.8.1 Homeocan Company Information
11.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Homeocan Main Business Overview
11.8.5 Homeocan Latest Developments
11.9 Clinigen Group
11.9.1 Clinigen Group Company Information
11.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Clinigen Group Main Business Overview
11.9.5 Clinigen Group Latest Developments
11.10 Vanda Pharma
11.10.1 Vanda Pharma Company Information
11.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Vanda Pharma Main Business Overview
11.10.5 Vanda Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (2021-2032)
2.1.2 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-24-hour Sleep-wake Disorder Treatment by Country/Region (2021, 2025 & 2032)
2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
2.2.1 Prescription Drugs
2.2.2 OTC
2.2.3 Non-24-hour Sleep-wake Disorder Treatment Market Size by Type
2.2.3.1 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
2.3 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
2.3.4.1 Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SIZE BY PLAYER
3.1 Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Player
3.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2021-2026)
3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT BY REGION
4.1 Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.4 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.5 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026)
5.2 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
5.3 Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026)
6.2 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
6.3 APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment by Region (2021-2026)
8.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST
10.1 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.1.2 Americas Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.3 APAC Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.4 Europe Non-24-hour Sleep-wake Disorder Treatment Forecast
10.1.5 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2 Americas Non-24-hour Sleep-wake Disorder Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.2 Canada Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.3 Mexico Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.2.4 Brazil Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3 APAC Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.3.1 China Non-24-hour Sleep-wake Disorder Treatment Market Forecast
10.3.2 Japan Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.3 Korea Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.4 Southeast Asia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.5 India Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.3.6 Australia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4 Europe Non-24-hour Sleep-wake Disorder Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.2 France Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.3 UK Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.4 Italy Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.4.5 Russia Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.2 South Africa Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.3 Israel Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.5.4 Turkey Market Non-24-hour Sleep-wake Disorder Treatment Forecast
10.6 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Type (2027-2032)
10.7 Global Non-24-hour Sleep-wake Disorder Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-24-hour Sleep-wake Disorder Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mylan Main Business Overview
11.2.5 Mylan Latest Developments
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Information
11.3.2 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Nature’s Bounty Main Business Overview
11.3.5 Nature’s Bounty Latest Developments
11.4 Otsuka Pharma (Pharmavite)
11.4.1 Otsuka Pharma (Pharmavite) Company Information
11.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Otsuka Pharma (Pharmavite) Main Business Overview
11.4.5 Otsuka Pharma (Pharmavite) Latest Developments
11.5 Boiron
11.5.1 Boiron Company Information
11.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boiron Main Business Overview
11.5.5 Boiron Latest Developments
11.6 Miers Laboratories
11.6.1 Miers Laboratories Company Information
11.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Miers Laboratories Main Business Overview
11.6.5 Miers Laboratories Latest Developments
11.7 Genexa
11.7.1 Genexa Company Information
11.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Genexa Main Business Overview
11.7.5 Genexa Latest Developments
11.8 Homeocan
11.8.1 Homeocan Company Information
11.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Homeocan Main Business Overview
11.8.5 Homeocan Latest Developments
11.9 Clinigen Group
11.9.1 Clinigen Group Company Information
11.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Clinigen Group Main Business Overview
11.9.5 Clinigen Group Latest Developments
11.10 Vanda Pharma
11.10.1 Vanda Pharma Company Information
11.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Offered
11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Vanda Pharma Main Business Overview
11.10.5 Vanda Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-24-hour Sleep-wake Disorder Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prescription Drugs
Table 4. Major Players of OTC
Table 5. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 8. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 11. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player (2021-2026)
Table 13. Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Products Offered
Table 14. Non-24-hour Sleep-wake Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 19. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-24-hour Sleep-wake Disorder Treatment
Table 39. Key Market Challenges & Risks of Non-24-hour Sleep-wake Disorder Treatment
Table 40. Key Industry Trends of Non-24-hour Sleep-wake Disorder Treatment
Table 41. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Teva Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 46. Teva Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 47. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Teva Main Business
Table 49. Teva Latest Developments
Table 50. Mylan Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 51. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 52. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Mylan Main Business
Table 54. Mylan Latest Developments
Table 55. Nature’s Bounty Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 56. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 57. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Nature’s Bounty Main Business
Table 59. Nature’s Bounty Latest Developments
Table 60. Otsuka Pharma (Pharmavite) Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 61. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 62. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Otsuka Pharma (Pharmavite) Main Business
Table 64. Otsuka Pharma (Pharmavite) Latest Developments
Table 65. Boiron Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 66. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 67. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Boiron Main Business
Table 69. Boiron Latest Developments
Table 70. Miers Laboratories Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 71. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 72. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Miers Laboratories Main Business
Table 74. Miers Laboratories Latest Developments
Table 75. Genexa Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 76. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 77. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Genexa Main Business
Table 79. Genexa Latest Developments
Table 80. Homeocan Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 81. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 82. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Homeocan Main Business
Table 84. Homeocan Latest Developments
Table 85. Clinigen Group Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 87. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Clinigen Group Main Business
Table 89. Clinigen Group Latest Developments
Table 90. Vanda Pharma Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 92. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Vanda Pharma Main Business
Table 94. Vanda Pharma Latest Developments
Table 1. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-24-hour Sleep-wake Disorder Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prescription Drugs
Table 4. Major Players of OTC
Table 5. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 8. Non-24-hour Sleep-wake Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 11. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player (2021-2026)
Table 13. Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Products Offered
Table 14. Non-24-hour Sleep-wake Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 19. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-24-hour Sleep-wake Disorder Treatment
Table 39. Key Market Challenges & Risks of Non-24-hour Sleep-wake Disorder Treatment
Table 40. Key Industry Trends of Non-24-hour Sleep-wake Disorder Treatment
Table 41. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Teva Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 46. Teva Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 47. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Teva Main Business
Table 49. Teva Latest Developments
Table 50. Mylan Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 51. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 52. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Mylan Main Business
Table 54. Mylan Latest Developments
Table 55. Nature’s Bounty Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 56. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 57. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Nature’s Bounty Main Business
Table 59. Nature’s Bounty Latest Developments
Table 60. Otsuka Pharma (Pharmavite) Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 61. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 62. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Otsuka Pharma (Pharmavite) Main Business
Table 64. Otsuka Pharma (Pharmavite) Latest Developments
Table 65. Boiron Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 66. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 67. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Boiron Main Business
Table 69. Boiron Latest Developments
Table 70. Miers Laboratories Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 71. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 72. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Miers Laboratories Main Business
Table 74. Miers Laboratories Latest Developments
Table 75. Genexa Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 76. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 77. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Genexa Main Business
Table 79. Genexa Latest Developments
Table 80. Homeocan Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 81. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 82. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Homeocan Main Business
Table 84. Homeocan Latest Developments
Table 85. Clinigen Group Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 87. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Clinigen Group Main Business
Table 89. Clinigen Group Latest Developments
Table 90. Vanda Pharma Details, Company Type, Non-24-hour Sleep-wake Disorder Treatment Area Served and Its Competitors
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Offered
Table 92. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Vanda Pharma Main Business
Table 94. Vanda Pharma Latest Developments
LIST OF FIGURES
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-24-hour Sleep-wake Disorder Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country/Region (2025)
Figure 8. Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type in 2025
Figure 10. Non-24-hour Sleep-wake Disorder Treatment in Hospital Pharmacies
Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Market: Hospital Pharmacies (2021-2026) & ($ millions)
Figure 12. Non-24-hour Sleep-wake Disorder Treatment in Retail Pharmacies
Figure 13. Global Non-24-hour Sleep-wake Disorder Treatment Market: Retail Pharmacies (2021-2026) & ($ millions)
Figure 14. Non-24-hour Sleep-wake Disorder Treatment in Other
Figure 15. Global Non-24-hour Sleep-wake Disorder Treatment Market: Other (2021-2026) & ($ millions)
Figure 16. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application in 2025
Figure 17. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player in 2025
Figure 18. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-24-hour Sleep-wake Disorder Treatment Value Market Share by Country in 2025
Figure 24. United States Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-24-hour Sleep-wake Disorder Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country/Region (2025)
Figure 8. Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type in 2025
Figure 10. Non-24-hour Sleep-wake Disorder Treatment in Hospital Pharmacies
Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Market: Hospital Pharmacies (2021-2026) & ($ millions)
Figure 12. Non-24-hour Sleep-wake Disorder Treatment in Retail Pharmacies
Figure 13. Global Non-24-hour Sleep-wake Disorder Treatment Market: Retail Pharmacies (2021-2026) & ($ millions)
Figure 14. Non-24-hour Sleep-wake Disorder Treatment in Other
Figure 15. Global Non-24-hour Sleep-wake Disorder Treatment Market: Other (2021-2026) & ($ millions)
Figure 16. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application in 2025
Figure 17. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Player in 2025
Figure 18. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-24-hour Sleep-wake Disorder Treatment Value Market Share by Country in 2025
Figure 24. United States Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-24-hour Sleep-wake Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-24-hour Sleep-wake Disorder Treatment Market Size 2027-2032 ($ millions)
